Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
U2OS |
Human bone osteosarcoma cell line | ATCC HTB-96 | Human | bone | cell line | adherent | siRNA | Metafectene PRO | publication | E. Pesarchuk, 2016, Dissertation, Universtity of Vancouver | Link | ||
U2OS |
Human bone osteosarcoma cell line | ATCC HTB-96 | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | Y. Martin et al., Oncogene, 2015, 34:1058-1063; doi:10.1038/onc.2014.38 | ||
U2OS |
Human bone osteosarcoma cell line | ATCC HTB-96 | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S. Hernández-Pérez et al., Oncogene, 2017, 36: 4802-4809, doi:10.1038/onc.2017.21 | ||
U251 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | siRNA | cotransfection (plasmid/siRNA) | K2 Transfection System | publication | P. D’Arrigo et al., Cell Death Discovery, 2019, 5:137, doi.org/10.1038/s41420-019-0216-0 | Link | ||
U251 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | P. D’Arrigo et al., Oncotarget, 2017, 8 (40): 68291-68304 | Link | ||
U251 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | M. B. Morelli et al., Oncotarget, 2016, 7 (28): 43654-43668 | Link | ||
U251 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | M. Tufano et al., Cells, 2021, 10, 2366. https://doi.org/10.3390/cells10092366 | Link | ||
U251 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | P. D’Arrigo et al., Cell Death Discovery, 2019, 5:137, doi.org/10.1038/s41420-019-0216-0 | Link | ||
TM-GBM |
Human Glioma spheroides obtained by microdissection of U87MG xenografted mice brain | Human | brain | cell line | adherent | siRNA | cotransfection (plasmid/siRNA) | K2 Transfection System | publication | P. D’Arrigo et al., Cell Death Discovery, 2019, 5:137, doi.org/10.1038/s41420-019-0216-0 | Link | ||
TM-GBM |
Human Glioma spheroides obtained by microdissection of U87MG xenografted mice brain | Human | brain | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | P. D’Arrigo et al., Cell Death Discovery, 2019, 5:137, doi.org/10.1038/s41420-019-0216-0 | Link | ||
THP-1 |
Human monocytic carcinoma cell line | ATCC TIB 202 | Human | immune system | cell line | suspension | siRNA | RNA-Interference | Metafectene | publication | S.-K. Kim et al., Cellular & Molecular Immunology, 2017, 14: 349-359 | Link | |
THP-1 |
Human monocytic carcinoma cell line | ATCC TIB 202 | Human | immune system | cell line | suspension | siRNA | RNA-Interference | Metafectene | publication | S. Diaz-Moralli et al., Oncotarget, 2016, 7 (32): 51876-51897 | Link | |
THP-1 |
Human monocytic carcinoma cell line | ATCC TIB 202 | Human | immune system | cell line | suspension | siRNA | RNA-Interference | Metafectene PRO | publication | B. Landry et al., PLoS ONE, 2012, 7(8): e44197, doi:10.1371/journal.pone.0044197 | Link | |
TFK-1 |
Human bile duct cholangiocarcinoma cell line | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | N. Golob‑Schwarzl et al., J. of Cancer Res. and Clin. Oncology, 2019, 145: 2699–2711, doi.org/10.1007/s00432-019-03030-x | Link | ||
TCA8113 |
Human oral squamous cell carcinoma cell line | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | M. Xu et al., PLoS ONE, 2015, 10(3):e0121439; doi:10.1371/journal.pone.0121439 | Link | ||
T98G |
Human brain glioblastoma cell line | ATCC CRL-1690 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | D. Alcantara, PhD Thesis, 2012, University of Sussex | Link | |
T98G |
Human brain glioblastoma cell line | ATCC CRL-1690 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | M. Alagoz et al., Nucleic Acids Res., Mar 2014; 42: 3089 - 3103 | Link | |
T98G |
Human brain glioblastoma cell line | ATCC CRL-1690 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | D. Guardavaccaro, Dissertation, 2012, Universita degli Studi della Tuscia | Link | |
T98G |
Human brain glioblastoma cell line | ATCC CRL-1690 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. M. McDonell et al., Nat. Genet., 2013, 45(5): 556–562, doi:10.1038/ng.2602 | Link | |
T98G |
Human brain glioblastoma cell line | ATCC CRL-1690 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | application note | ![]() |
||
T98G |
Human brain glioblastoma cell line | ATCC CRL-1690 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | M.C. Burger et al., Int. J. of Oncology, 2012, 41: 235-241, DOI: 10.3892/ijo.2012.1446 | Link | |
T98 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | M. B. Morelli et al., Oncotarget, 2016, 7 (28): 43654-43668 | Link | ||
T-47D |
Human breast cancer cel line | ATCC HTB-133 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | I. H. Polat, Doctoral Thesis, 2016, University of Barcelona | Link | |
T-47D |
Human breast cancer cel line | ATCC HTB-133 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | C. Thirukkumaran et al., PLOSONE 2017, DOI:10.1371/journal.pone.0168233 | Link | |
T-24 |
Human urinary bladder cancer cell line | ATCC HTB-4 | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | M. Endres et al., Oncotarget, 2016, 7(39): 64244-64259 | Link |